9637 — Alebund Pharmaceuticals (Jiangsu) Cashflow Statement
0.000.00%
Last trade - 00:00- HK$6.09bn
- HK$5.13bn
- CNY30.56m
Annual cashflow statement for Alebund Pharmaceuticals (Jiangsu), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -335 | -752 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 46.6 | 371 |
| Unusual Items | ||
| Equity in Net Earnings/Losses | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 26 | 48.2 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -250 | -288 |
| Capital Expenditures | -237 | -102 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | -20.7 | -135 |
| Sale/Maturity of Investment | ||
| Change in Net Investments | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -257 | -237 |
| Financing Cash Flow Items | -388 | -21 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 788 | 542 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 281 | 14.6 |